US$ 24.22
medicaid glp-1 As demand for weight-loss drugs rises, states grapple with coverage • Missouri Independent Save on GLP-1s with SingleCare
Description
GLP-1 GIP NASH Trial NEJM 2024 View on PubMed 2023 Diabetes Care Mechanism Glucagon Co-Agonism Amplifies GLP-1-Mediated Weight Loss via Brown Adipose Thermogenesis Finding: In mouse models, adding glucagon receptor agonism to GLP-1R agonism increased brown adipose tissue thermogenic gene expression (UCP1 +62%, PGC-1 +44%) and significantly amplified fat oxidation (+38%)

The result is a catch-22: patients must persist long enough to demonstrate clinical benefit, yet the financial burden often prevents that persistence, undermining the very outcomes needed to justify reimbursement
Noom Med includes all that, in addition to a prescription for a GLP-1
166 VarinE
